Literature DB >> 28710032

MicroRNA-136 inhibits colon cancer cell proliferation and invasion through targeting liver receptor homolog-1/Wnt signaling.

Qinggong Yuan1, Gang Cao1, Junhui Li1, Yan Zhang1, Wenbin Yang2.   

Abstract

An increasing number of studies have reported that microRNAs (miRNAs) are involved in the malignant behavior of colon cancer cells through directly targeting multiple tumor suppressors or oncogenes. The expression and role of miR-136 has been reported in several types of human cancer. However, the role of miR-136 in colon cancer remains unclear. In this study, we aimed to investigate the expression and function of miR-136 in colon cancer and the potential underlying mechanism. Here, we found that miR-136 was decreased in colon cancer cell lines and tissues. Overexpression of miR-136 inhibited the proliferation and invasion in SW480 and HCT116 cell lines while suppression of miR-136 exhibited the opposite effect. Liver receptor homolog-1 (LRH-1) was identified as a direct target gene of miR-136. Notably, miR-136 overexpression suppressed LRH-1 expression as well as Wnt signaling in SW480 and HCT116 cell lines. The miR-136 expression level inversely correlated with LRH-1 mRNA expression in colon cancer specimens. Moreover, overexpression of LRH-1 partially reversed the miR-136-induced antitumor effect in SW480 and HCT116 cell lines. Taken together, these findings suggest that miR-136 functions as a negative regulator in colon cancer progression by targeting LRH-1 and that miR-136 downregulation contributes to high expression of LRH-1 and aberrant activation of Wnt signaling, leaving open the possibility that miR-136 may serve as a potential therapeutic target for colon cancer.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Colon cancer; LRH-1; Wnt; miR-136

Mesh:

Substances:

Year:  2017        PMID: 28710032     DOI: 10.1016/j.gene.2017.07.031

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  14 in total

1.  Downregulation of miR-136 promotes the progression of osteosarcoma and is associated with the prognosis of patients with osteosarcoma.

Authors:  Yanchen Chu; Xiaoli Hu; Guangfeng Wang; Zhijie Wang; Yanjin Wang
Journal:  Oncol Lett       Date:  2019-04-01       Impact factor: 2.967

Review 2.  MicroRNAs regulating Wnt signaling pathway in colorectal cancer: biological implications and clinical potentials.

Authors:  Faeze Ahmadi Beni; Mohammad Kazemi; Hassan Dianat-Moghadam; Mohadeseh Behjati
Journal:  Funct Integr Genomics       Date:  2022-10-20       Impact factor: 3.674

3.  Liquid Biopsy for Colorectal Adenoma: Is the Exosomal miRNA Derived From Organoid a Potential Diagnostic Biomarker?

Authors:  Tomoyuki Handa; Masatake Kuroha; Hiroshi Nagai; Yusuke Shimoyama; Takeo Naito; Rintaro Moroi; Yoshitake Kanazawa; Hisashi Shiga; Yoichi Kakuta; Yoshitaka Kinouchi; Atsushi Masamune
Journal:  Clin Transl Gastroenterol       Date:  2021-05-12       Impact factor: 4.396

4.  Association between NR5A2 and the risk of pancreatic cancer, especially among Caucasians: a meta-analysis of case-control studies.

Authors:  Qun Chen; Hao Yuan; Guo-Dong Shi; Yang Wu; Dong-Fang Liu; Yu-Ting Lin; Lei Chen; Wan-Li Ge; Kuirong Jiang; Yi Miao
Journal:  Onco Targets Ther       Date:  2018-05-09       Impact factor: 4.147

5.  Aspirin inhibits hepatocellular carcinoma cell proliferation in vitro and in vivo via inducing cell cycle arrest and apoptosis.

Authors:  Tingting Shi; Koji Fujita; Jian Gong; Mai Nakahara; Hisakazu Iwama; Shi Liu; Hirohito Yoneyama; Asahiro Morishita; Takako Nomura; Joji Tani; Kei Takuma; Tomoko Tadokoro; Takashi Himoto; Kyoko Oura; Kunihiko Tsutsui; Hideki Kobara; Tsutomu Masaki
Journal:  Oncol Rep       Date:  2020-05-29       Impact factor: 3.906

6.  A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.

Authors:  Dong-Yu Wang; Deena M A Gendoo; Yaacov Ben-David; James R Woodgett; Eldad Zacksenhaus
Journal:  Breast Cancer Res       Date:  2019-01-31       Impact factor: 6.466

7.  EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer.

Authors:  Berta Roman-Canal; Jordi Tarragona; Cristian Pablo Moiola; Sònia Gatius; Sarah Bonnin; Maria Ruiz-Miró; José Enrique Sierra; Maria Rufas; Esperanza González; José M Porcel; Antonio Gil-Moreno; Juan M Falcón-Pérez; Julia Ponomarenko; Xavier Matias-Guiu; Eva Colas
Journal:  J Transl Med       Date:  2019-06-20       Impact factor: 5.531

8.  MiR-34b inhibits the proliferation and promotes apoptosis in colon cancer cells by targeting Wnt/β-catenin signaling pathway.

Authors:  Kailun Ye; Chunhua Xu; Tongguan Hui
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

9.  LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.

Authors:  Chunyong Han; Yiwei Fu; Ni Zeng; Jian Yin; Qian Li
Journal:  Aging (Albany NY)       Date:  2020-02-17       Impact factor: 5.682

10.  Long Non-Coding RNA Cancer Susceptibility 9 (CASC9) Up-Regulates the Expression of ERBB2 by Inhibiting miR-193a-5p in Colorectal Cancer.

Authors:  Yuansheng Ding; Xiaoyan Li; Yucui Zhang; Jie Zhang
Journal:  Cancer Manag Res       Date:  2020-02-20       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.